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Abstract
BAHD1 is a vertebrate protein that promotes heterochromatin formation and gene repres-
sion in association with several epigenetic regulators. However, its physiological roles
remain unknown. Here, we demonstrate that ablation of the Bahd1 gene results in hypocho-
lesterolemia, hypoglycemia and decreased body fat in mice. It also causes placental growth
restriction with a drop of trophoblast glycogen cells, a reduction of fetal weight and a high
neonatal mortality rate. By intersecting transcriptome data from murine Bahd1 knockout
(KO) placentas at stages E16.5 and E18.5 of gestation, Bahd1-KO embryonic fibroblasts,
and human cells stably expressing BAHD1, we also show that changes in BAHD1 levels
alter expression of steroid/lipid metabolism genes. Biochemical analysis of the BAHD1-
associated multiprotein complex identifies MIER proteins as novel partners of BAHD1 and
suggests that BAHD1-MIER interaction forms a hub for histone deacetylases and methyl-
transferases, chromatin readers and transcription factors. We further show that overexpres-
sion of BAHD1 leads to an increase of MIER1 enrichment on the inactive X chromosome
(Xi). In addition, BAHD1 and MIER1/3 repress expression of the steroid hormone receptor
genes ESR1 and PGR, both playing important roles in placental development and energy
metabolism. Moreover, modulation of BAHD1 expression in HEK293 cells triggers epige-
netic changes at the ESR1 locus. Together, these results identify BAHD1 as a core
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body fat storage and suggest that its dysfunction may contribute to several human
diseases.
Author Summary
The importance of epigenetics in regulation and dysfunction of metabolic pathways is
increasingly recognized but the underlying mechanisms and molecular actors involved
remain incompletely characterized. Here, we provide evidence that the heterochromatini-
zation factor BAHD1 cooperates with MIER proteins to assemble chromatin-repressive
complexes that control a network of metabolic genes involved in placental and fetal
growth and in cholesterol homeostasis.
Introduction
Chromatin-based transcriptional repression is mediated by macromolecular complexes con-
taining proteins involved in chromatin writing, reading, erasing and remodeling activities. The
combinatorial assembly of subunits with transcription factors affects cell-specific gene expres-
sion in response to developmental, physiological or environmental stimuli. Chromatin-repres-
sive complexes control key pathways during embryonic development and adult life; as a
consequence, deregulation or abnormalities in their components can lead to a wide range of
pathological processes [1, 2]. The importance of chromatin-modifiers in development, cell dif-
ferentiation and disease is well illustrated for three complexes containing the histone deacety-
lases HDAC1 and HDAC2: NuRD [3, 4], Sin3A [5] and CoREST [6, 7] (For reviews, see [2, 8–
10]). By a proteomic approach, we found that the Bromo-Adjacent-Homology domain-con-
taining 1 (BAHD1) protein co-purifies with HDAC1/2, together with heterochromatin pro-
teins HP1 and KAP1 (or TRIM28) in human embryonic kidney (HEK) 293 cells, suggesting
that BAHD1 is a core component of a novel HDAC1/2-associated complex [11]. BAHD1 also
interacts with the Methyl-CpG-binding protein MBD1 and the H3K9 methyltransferases
(KMT) SETDB1 [12] and SUV39H1 [13] and acts as a repressor, pointing to a role of BAHD1
in heterochromatin-mediated transcriptional repression [12]. In agreement with this, overex-
pression of BAHD1 in human cells induces large-scale chromatin condensation [12] and
changes in the DNAmethylation landscape [14].
BAHD1-associated heterochromatic domains lack acetyl histone H4 and partially overlap
with HP1α, a marker of constitutive heterochromatin, and/or with H3 trimethylated at lysine
27 (H3K27me3), a marker of facultative heterochromatin [12]. Furthermore, when overex-
pressed in human female cells, BAHD1 is enriched at the inactive X chromosome (Xi), a para-
digm of facultative heterochromatin [12]. A study in mouse embryonic stem cells (mESCs)
recently reported that BAHD1, HDAC1 and HDAC2 are pulled-down by CDYL, a transcrip-
tional co-repressor that may play a role in the maintenance of the Xi [15]. Taken together,
these data suggest that BAHD1 is a component of HDAC1/2-associated complexes involved in
a variety of epigenetic mechanisms.
A single gene encodes BAHD1 in vertebrates and no ortholog is found in invertebrates or
plants, suggesting that BAHD1 has vertebrate-specific functions. However, the low expression
of BAHD1 in cell lines has hampered its functional characterization and, so far, the BAHD1
regulatory gene network is poorly characterized. We identified the insulin-like growth factor II
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(IGF2) transcript and its antisense transcript (IGF2AS) as BAHD1 targets in HEK293 embryonic
cells [12]. We also demonstrated that infection by a bacterial pathogen triggers BAHD1-mediated
repression of Interferon-Stimulated Genes (ISGs) in epithelial cells [11]. However, apart from
bacterial infection, signals that control the expression and/or activity of BAHD1 are unknown.
The aim of the present study was to determine the physiological functions of BAHD1. We
show that disruption of the Bahd1 gene in the mouse leads to a placental growth defect associ-
ated with low birth weight and neonatal death, hypocholesterolemia and decreased body fat in
surviving adults. Proteomic studies of BAHD1-associated proteins identify MIER proteins as
novel BAHD1 partners. Our extensive characterization of the transcriptome strongly suggests
that BAHD1-MIER complexes repress genes involved in the control of steroid/lipid metabo-
lism both in mouse and human cells.
Results
Bahd1-deficient mice display hyporcholesterolemia, hypoglycemia and
a lower body weight
We searched for tissue-specific expression of the BAHD1 gene by a survey of referenced tran-
scriptome datasets (S1 Table) and found that BAHD1mRNA levels are low and do not vary
much between tissues, when compared to a set of housekeeping or tissue-specific genes. This
observation is consistent with the lack of detection of the endogenous BAHD1 protein in mam-
malian cultured cells and suggests that BAHD1 basal levels are low. In order to identify func-
tions of BAHD1 in biological processes, we studied the physiological consequences of BAHD1
inactivation by performing a large-scale phenotyping of Bahd1 haplo-deficient (Bahd1+/-) mice
[11]. The analysis was carried out on 18 heterozygous (HET) and 16 wild type (WT) littermates
(results are detailed in S1 Text and S2 Table). Mice were first fed a standard chow diet (CD) for
14 weeks and then a high fat/high carbohydrate diet (HFHCD) for 16 weeks. HET Bahd1+/-
mice did not show any morphological, sensory or cardiac abnormality and no change in bone
density, body weight and fat, when compared to WT littermates, and the blood chemistry and
hematology parameters were within the normal range. However, some slight and gender-spe-
cific modifications of glucose or cholesterol parameters were observed in HET mutants. At the
age of 10 weeks, HET male mice displayed a significant hypoglycemia when compared to WT
mice (Fig 1A). After the switch to HFHCD, blood levels of glucose remained lower in 30-week-
old HET than in WTmale mice, although difference did not then reach statistical significance
(S2A Table). In contrast to males, glycemia was not affected in female HET mice whatever the
diet (Fig 1A) but female HET fed with HFHCD displayed a slight decrease in blood levels of
total cholesterol, high-density lipoprotein (HDL) and low-density lipoprotein (LDL) compared
to WT littermates (Fig 1B). However, values were statistically significant only for LDL concen-
trations (S2B Table).
We next crossed Bahd1-heterozygous mice to evaluate potential metabolism defects in the
Bahd1-null context. Most Bahd1-/- (KO) pups died within the first days of life, indicating that
the Bahd1-null mutation leads to perinatal death. Only 5 Bahd1-/- out of 200 genotyped pups
(2.5%) survived birth. At six weeks, these 5 survivors, all males, displayed reduced sizes and
weights compared to control littermates (Fig 1C). After several months, they reached the length
of Bahd1+/+ littermates (Fig 1C and 1D), but kept a significant lower body weight (Fig 1E),
characterized by reduced fat and lean mass (Fig 1F). Quantification of blood parameters
highlighted lower levels of total cholesterol, HDL and LDL in plasma of Bahd1-/- mice than in
Bahd1+/+ littermates at 3–5 months (S1A Fig), 7 and 18 months of age (Fig 1G and 1H). Glu-
cose and leptin levels were also significantly lower in 18 month-old Bahd1-/- mice than in
Bahd1+/+ littermates (Fig 1H). The other measured blood parameters were not significantly
Biological Functions of BAHD1
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Fig 1. Bahd1-knockout mice display decreased weight and fat mass and lower cholesterol, glucose
and leptin levels. A-B. Plasma levels of glucose (A) or of total cholesterol, HDL and LDL (B) in Bahd1wild-
type (WT) and -heterozygous (HET) male (top) or female (bottom) mice, 10-week-old fed a chow diet (CD) or
Biological Functions of BAHD1
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different between KO and WTmice (i.e. insulin, adiponectin, Fig 1G and 1H; triglycerides, free
fatty acids, glycerol, aspartate and alanine amino transferases, urea, creatinine, albumin, gluca-
gon, GIP, S1B Fig). Together, these results demonstrate a biological function of BAHD1 in con-
trolling lipid and carbohydrate metabolism.
BAHD1 is required for mouse placental and fetal growth
The high neonatal mortality rate of BAHD1-KO pups suggested that BAHD1 could have impor-
tant functions during fetal life. In order to address this question, we examined embryos just
before birth at the embryonic day 18.5 (E18.5). Bahd1-/- fetuses were present at Mendelian fre-
quency, had normal morphology, were alive and exhibited the breathing reflex. However, their
weight was decreased by 30% (Fig 2A) when compared toWT or HET fetuses. In addition,
Bahd1-/- embryos exhibited a smaller placenta, with a reduction of 30% in the circumference and
55% of the area (Fig 2B), when compared to placentas of WT or HET embryos. At an earlier
stage (E16.5), Bahd1-/- placentas were also smaller than Bahd1+/+ ones (Fig 2B). Histology of pla-
centa sections with hematoxylin and eosin (HE) staining showed that Bahd1-/- placentas com-
prised the two fetal compartments (labyrinthine zone (Lz) and junctional zone (Jz)) and the
maternal compartment (decidua basalis (Db)). However, the Lz surface area was significantly
reduced and the Jz and Db were thinner in Bahd1-/- placentas than in control littermates (Fig
2C). The junctional zone plays an important role in hormone synthesis, while the labyrinthine
zone is critical for materno-foetal nutrient exchange [16, 17]. The Jz comprises fetal spongiotro-
phoblast cells and trophoblast glycogen cells (GCs). The exact origin and function of GCs is
unknown, but they are believed to provide an important glucose supply for fetoplacental develop-
ment. Evidence indicates that they differentiate early (E.6.5) in the ectoplacental cone at the ori-
gin of the Jz and migrate into the maternal decidua at about E12.5 [18, 19]. We used periodic
acid-Shiff (PAS) staining to examine if GCs were altered by the Bahd1 null mutation. PAS stain-
ing confirmed the reduced thickness of Jz and Db in Bahd1-/- relative to Bahd1+/+ placentas at
E16.5 and showed a severe reduction in the number of PAS-positive GCs both in the Jz and the
Db (Fig 1D and S2A Fig). In contrast, histology of the fetal liver at E16.5 did not reveal any
noticeable difference between Bahd1-KO andWT embryos (S2B Fig). Together, these results
indicate that BAHD1 is required for a normal placental development and intra-uterine fetal
growth. BAHD1mutants may die after birth frommetabolic defects, or secondary to altered pla-
cental exchange prenatally, impairing the development of energy stores.
Expression of a set of steroid metabolism genes and imprinted genes is
altered in Bahd1-/- placentas
To examine the consequence of BAHD1 deficiency on the placental transcriptome, we isolated
RNA from Bahd1-/- placentas at stages E16.5 (n = 6 per genotype) and at stage E18.5 (n = 3 per
genotype) to perform a comparative microarray analysis using Affymetrix mouse arrays. The
Bahd1-null mutation altered expression of 397 and 1396 genes (FDR-BH< 0.05) at E16.5 and at
E18.5, respectively, with a much higher proportion of up-regulated genes (70–80%) than down-
30-week-old fed 14 weeks CD followed by 16 weeks HFHC (n = 8-10/group. C. Representative macroscopic
images of Bahd1-WT and -knockout (KO) mice at 6 weeks and 9 months. D. Body length at 9 months. E.
Body weight curve of Bahd1-WT and KOmice between the ages of 7 to 17 months (n = 5/group). F.
Quantification of body fat mass and lean by QNMR analysis on 15 month-old animals (n = 4/group).G.
Plasma levels of glucose, total cholesterol, HDL, insulin, leptin and adiponectin in 16-hours fasted 7-month-
old WT and KOmice fed a normal diet (n = 4/group). H. Plasma levels of the same parameters in the same
animals one year later (18 month-old). All data are expressed as the mean ± SE (* P<0.05; ** P<0.01;
*** P< 0.005).
doi:10.1371/journal.pgen.1005898.g001
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Fig 2. BAHD1 plays a role in fetal and placental growth. A. Representative images of Bahd1+/+ and
Bahd1−/− fetuses at E18.5 and quantification of fetus weight (on the right, * P < 0.05).B. Representative
images of Bahd1−/− and Bahd1+/+ placentas at E18.5 and E16.5. Scale bar, 200 mm. Quantification of areas
Biological Functions of BAHD1
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regulated genes (20–30%), consistent with a role for BAHD1 in transcriptional repression (Fig
3A). 65% of genes deregulated in E16.5 Bahd1-KO placentas remained similarly deregulated at
the E18.5 stage (214 up-regulated and 46 down-regulated genes, S3 Table). We used the DAVID
software to classify genes based on Gene Ontology (GO) [20] and highlight the most significant
biological processes that could be altered by BAHD1 deficiency. At the E16.5 stage, the most sig-
nificant gene cluster (P value< 5.10−4) was a group of 16 genes involved in steroid metabolic
processes (Fig 3B and S4A Table). Notably, 11 of these genes remained deregulated in Bahd1-/-
E18.5 placentas: 7 genes up-regulated (Apoc3, Atp8b1, Cyp11A1, Insig2, Osbpl5, Pbx1, VldlR) and
4 genes down-regulated (Fabp6,Hsd17b2,Hsd17b7, LepR) (S3 Table). In addition, two steroid
hormone receptor genes, the estrogen receptor alpha gene Esr1 and progesterone receptor gene
Pgr, were up-regulated in Bahd1-/- placentas, both in males and females embryos and at both ges-
tational stages, as confirmed by Real time quantitative PCR (RT-qPCR) analysis (Fig 3C).
Groups of genes involved in the response to oxidative stress, skeletal system development and
blood vessel development were also over-represented in Bahd1-KO placentas (S4 Table). Several
of these genes are known to be involved in placental morphogenesis, such asGja1/Cx43, Cxcl14,
Mmp2,Mmp14, Runx1 (up-regulated) and Ada, Adm, Gcm1, Gjb5 (down-regulated). Altered
expression of these genes in Bahd1-KOmice is consistent with an abnormal placentation. RT-
qPCR analysis of a set of transcripts confirmed the transcriptome data (Fig 3C and 3D).
Several genes previously shown to be imprinted in the mouse during development or in the
adult [21] were also up-regulated in Bahd1-KO placentas. Imprinted genes, expressed from only
one of the parental alleles, play important functions during mammalian development, particu-
larly in the placenta [22]. The parental conflict hypothesis of imprinting proposes that mater-
nally− or paternally−expressed imprinted genes restrict or increase the energy expenditure,
respectively [23]. We have previously shown that in human embryonic cells BAHD1 repressed
IGF2 and IGF2AS [12], which are imprinted in many tissues. BAHD1 deficiency did not affect
Igf2 expression in murine placenta, but, the paternally−expressed Igf2as and ten maternally
−expressed putative imprinted (Ampd3, Ano1, Dcn, Gatm,Htra3, Osbpl5, Qpct, Tfpi2, Tnfrsf23
andWt1) were up-regulated in Bahd1-deficient E16.5 placentas, while one,Gpr1, was down-reg-
ulated. RT-qPCR assays confirmed these results using several other imprinted genes as negative
controls (Fig 3E). Most of these genes are imprinted only in the placenta. However, determining
placental specific imprinting can be confounded by maternally derived placental tissue and there
is controversy over the imprinted status of some of these genes [24]. Strikingly,Htra3, Tfpi2,
Ampd3, Gatm, Osbpl5,Qpct andWnt1 were also consistently up-regulated in Bahd1-deficient
E18.5 placentas (S3 Table) and may be functionally implicated in the impaired placental growth.
Steroid metabolism genes are also altered in Bahd1-/- mouse MEFs and
BAHD1-overexpressing human cells
Bahd1-KO fetuses exhibited a lower weight than Bahd1-WT. This phenotype could result from
placental dysfunction but also from deregulation of BAHD1 target genes in intra-embryonic
tissues. To address this point, we analyzed transcriptomes of mouse embryonic fibroblasts
derived from Bahd1-WT and -KO embryos at stage E13.5 (n = 3 per genotype). The results of
and circumferences of E18.5 placentas are shown on the right (Bahd1+/+, n = 4; Bahd1+/-, n = 11; Bahd1-/-;
n = 7). Data are expressed as mean ± SD (*P < 0.05). C. Histological analysis of Bahd1−/− and Bahd1+/+
placentas at E18.5 and E16.5. Placentas were collected, fixed and subjected to hematoxylin and eosin (HE)
staining. A representative image is shown. Scale bar: 1 mm.D. Periodic acid-Shiff (PAS) staining of the same
E16.5 placentas as in C, at three different scales. Scale bar, 1 mm (top), 250μm (bottom), 60 μm (squared
region). High magnification of vacuolated glycogen cells GCs (arrowheads) in the junctional zone is shown in
squared regions. Ms, mesometrial triangle; Db: decidua basalis; Jz junctional zone; Lz, labyrinthine zone.
doi:10.1371/journal.pgen.1005898.g002
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Fig 3. Loss or overexpression of BAHD1 alters expression of genes involved in steroid metabolism. A. Number of genes up- and down-regulated in
Bahd1-KO placentas or MEFs relative to WT counterparts. B.Gene ontology enrichment analysis of transcripts differentially expressed in Bahd1-KO relative
to WT placentas and MEFs, and in human HEK-BAHD1 cells relative to HEK-CT cells. The enrichment score represents the negative logarithm of the p-value
Biological Functions of BAHD1
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this analysis revealed 353 up-regulated and 139 down-regulated genes (FDR-BH< 0.05) in
Bahd1-KOMEFs, when compared to Bahd1-WTMEFs (Fig 3A). We focused on up-regulated
genes, as these likely contain those genes directly repressed by BAHD1. Strikingly, the most sig-
nificant biological process associated with up-regulated genes in Bahd1-KOMEFs was sterol
metabolism (Fig 3B). However, genes associated with this process were different to those
affected in Bahd1-KO placentas (S4C Table), suggesting that BAHD1-dependent gene net-
works are tissue-specific even though they may have a common function.
We next assessed whether BAHD1 has a similar role in repressing sterol metabolism genes in
human cells, by comparing transcriptomes of HEK293 cells stably overexpressing BAHD1
(HEK-BAHD1) to that of parental isogenic cells (HEK-CT), in which the BAHD1 protein is
undetectable [14]. This analysis identified 1148 transcripts (FDR-BH< 0.05) that were down-reg-
ulated in cells constitutively expressing the BAHD1 repressor. Once again, GO term classification
analysis of these transcripts highlighted sterol metabolism as the most significant biological pro-
cess (Fig 3B and S4D Table). Genes involved in lipid and hexose metabolism also grouped as sig-
nificant clusters. Although biological functions of BAHD1-associated chromatin repressive
complexes are likely to be cell type- and species-specific, and a transcriptome will identify direct
and indirect gene expression changes, BAHD1 bona fide target genes may be identified by com-
paring different biological systems (Fig 3F). Overlapping HEK-BAHD1 and Bahd1-KO E18.5 pla-
centa transcriptomes identified 107 potential BAHD1 targets (S5A Table and Fig 3F), the most
significant gene groups where those involved in the regulation of hormone levels (ALDH1A2,
BACE2, CAMK2G, CRABP2, LY6E, SCARB1, SLC16A2) and lipid biosynthetic processes
(ALDH1A2, CD81, EBP, ELOVL7, LASS4, LPL, LPCAT2, LTA4H, SCARB1)(S4E Table). Overlap-
ping HEK-BAHD1 and Bahd1-KOMEFs transcriptomes identified 44 potential BAHD1 target
genes (S5B Table and Fig 3F), the most statistically significant group in term of biological pro-
cesses including genes involved in sterol/steroid metabolism (DHCR24,HMGCS1, LDLR,
NSDHL, SC4MOL, SREBF2; S4F Table). Only six genes were altered consistently between all the
three transcriptome datasets (S5C Table). Using a tetracycline-inducible BAHD1HEK293 line
(HPT-BAHD1 cells, [11]), we confirmed that induction of BAHD1 expression (S3 Fig) is suffi-
cient to repress five transcripts involved in lipid/steroid metabolism (HMGCS1, LDLR,NSDHL,
CRABP2 and LASS4) (Fig 3G). Of note, no imprinted gene was found in this analysis, indicating
that the effect of the Bahd1-null mutation on this gene category is specific to the placenta. Alto-
gether, these findings show that changes in BAHD1 levels alter expression of gene networks con-
trolling steroid/lipid metabolism and hormone signaling pathways, which are key players in the
development of the placenta and in control of energy in the body.
BAHD1 co-purifies with MIER proteins, HDAC1/2 and several chromatin
regulators
Efforts to perform chromatin immunoprecipitation (ChIP) of BAHD1 in murine or human
cells using custom [12] or commercial BAHD1 antibodies repeatedly failed, preventing
evaluating the significance of gene ontology terms for differentially expressed RNAs. The top 10 annotation clusters are listed as derived from the DAVID
bioinformatics tool.C. Transcripts levels in Bahd1−/− placentas relative to Bahd1+/+ littermates at E16.5 (n = 6, with 3 males and 3 females for each genotype)
or E18.5 (n = 3 for each genotype) were quantified by RT-qPCR. Values are normalized byGapdh. Ywhaz is used as negative control. The differential
expression in Bahd1−/− placentas is shown (relative to that in Bahd1+/+ = 1). D. Relative transcripts levels for several genes in Bahd1−/− relative to Bahd1+/+
placentas at E18.5 (n = 3 for each genotype). E. Relative transcripts levels for imprinted genes in Bahd1−/− relative to Bahd1+/+ placentas at E16.5 (n = 4 for
each genotype). Values are normalized to Hprt, ActB and Tuba1a. F. Venn diagram depicting shared genes that are up-regulated in Bahd1-KO E18.5
placentas and MEFs and down-regulated in human HEK-BAHD1 cells.G. Relative transcripts levels for lipid metabolism genes in HPT-BAHD1 cells relative
to control HPT-CT. BAHD1 expression was induced with tetracycline for 30h. Data are expressed as mean ± SD (ns, non-significant; * P < 0.05;
** P < 0.005; *** P < 0.001).
doi:10.1371/journal.pgen.1005898.g003
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straightforward identification of genomic loci targeted by BAHD1 (BAHD1 ChIP is further
discussed in S1 Text). To get further clues on BAHD1 function, we searched for novel BAH-
D1-associated proteins in cells stably expressing His6-Protein-C-tagged-BAHD1
(HPT-BAHD1) by using tandem affinity chromatography purification (TAP) and Mass spec-
trometry (MS), as described previously [11]. We found that ~10 proteins reproducibly co-puri-
fied with BAHD1 after two successive purification steps (Fig 4A and S6 Table): the mesoderm
induction early response (MIER) proteins (MIER1, MIER2 and MIER3), HDAC1/2, HP1γ/β,
KAP1, CDYL1, KAP1, PPP2R1A, RUVBL2 and DDX17. Other polypeptides were consistently
detected in the first-step purification (HP1α, RUVBL1, CDYL2, DDX21, G9a, CHD3, S6
Table). Peptides matching with MBD1 were found in one TAP, in agreement with yeast two-
hybrid, co-immunoprecipitation and GST pulldown assays that previously showed that
BAHD1 interacts with MBD1 and HP1 [12]. Western blot analysis confirmed that BAHD1 co-
purifies with MBD1 and HP1γ together with MIER1, HDAC1, HDAC2, KAP1 and the H3K9
KMT G9a (Fig 4B and S4 Fig). These data suggest that BAHD1 and MIER proteins are subunits
of a macromolecular complex containing chromatin writers (e.g. G9a), readers (e.g. HP1α/β/γ,
CDYL1/2, MBD1), erasers (e.g. HDAC1/2) and remodelers (e.g. CHD3, RUVBL1/2).
We noticed that BAHD1 and MIER1 displayed conserved domains found in scaffolding
proteins of other HDAC1/2 complexes: the metastasis-associated protein (MTA) subunits of
NuRD [8, 25] and RERE/atrophin-2, a transcriptional repressor belonging to a poorly charac-
terized HDAC1/2 complex [26–28] (Fig 4C). BAHD1, MTA and RERE share a Bromo-Adja-
cent Homology (BAH) domain, which is known to promote protein-protein interactions and
binding to nucleosomes [25, 29, 30], while MIER1, MTA and RERE proteins contain juxta-
posed ELM2 and SANT domains that recruit HDACs [25]. Thus, BAHD1 and MIER1 could
cooperate to fulfill a function similar to that of MTA and RERE in other HDAC1/2 complexes
(Fig 4D). To investigate this hypothesis, we performed a series of co-immunoprecipitation
experiments on HEK293-FT cells transiently expressing tagged-versions of BAHD1 from plas-
mid vectors, since endogenous BAHD1 is undetectable in HEK293 cells. Reciprocal co-IP
assays with nuclear extracts confirmed association of endogenous MIER1 with V5-tagged
BAHD1 in HEK293-FT cells and their co-immunoprecipitation with HDAC2 and HP1γ (Fig
4E and S5 Fig). Likewise, BAHD1 tagged with the fluorescent protein citrine (YFPc-BAHD1)
pulled-down HDAC2, MIER1 and HP1γ (Fig 4F, lane 1).
BAHD1 harbors a N-terminal proline-rich region with the highest density of prolines found
between residues 239 to 361, a region termed the cPRR [31], and a C-terminal BAH domain
that interacts with the N-terminal tail of histone H3 [12] (Fig 4C). To assess the requirement of
specific protein domains in BAHD1 for productive interaction with MIER and HDACs, we
expressed truncated forms of YFPc-BAHD1 in HEK293-FT cells. As shown in Fig 4F and S5E
Fig, the deletion mutant YFPc-BAHD1-ΔcPRR lacking residues 239 to 361 co-immunoprecipi-
tated with HDAC2, MIER1 and HP1γ, as the full-length YFPc-BAHD1. In contrast, the dele-
tion mutant YFPc-BAHD1-ΔBAH lacking residues 592 to 780 encompassing the BAH624-780
domain failed to pull-down HDAC2 and MIER1, while retaining the ability to bind HP1γ. We
conclude that BAHD1 interaction with MIER1 and HDAC2 requires the integrity of the BAH
domain of BAHD1.
We also found that varying BAHD1 amounts has an impact on MIER1 subcellular localiza-
tion. First, MIER1 shifted from cytosolic to chromatin-bound fraction in response to induction
of BAHD1 expression in HPT-BAHD1 cells (Fig 5A). Second, microscopy experiments showed
that BAHD1 overexpression increased MIER1 nuclear staining and induced enrichment of
MIER1 at the heterochromatic inactive X chromosome (Xi) (Fig 5B and 5C). This effect was
not due to changes inMIER1 transcript levels (S3 Fig). The fact that BAHD1 levels dictate the
localization of MIER1 strongly suggests that BAHD1 and MIER1 form a stable chromatin-
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Fig 4. BAHD1 binds to MIER and HDACs. A-B. TAP-MS purification of the His6-Protein-
C-BAHD1-associated complex. Solubilized chromatin extracts (“Inputs”) from HPT-CT cells (“Control”) or
HPT-BAHD1 cells (“BAHD1”) were processed on anti–protein C affinity matrix (E1) and nickel-Sepharose
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bound complex. This hypothesis is also supported by results from the Heard laboratory [15]
showing that BAHD1, MIER1/2, HDAC1/2 and G9a co-immunoprecipitate with CDYL, a pro-
tein recruited to Xi in mouse ES cells and also found in our TAP assays (S6 Table).
Relationship between BAHD1 and metabolism-associated transcription
factors
We propose that BAHD1 andMIER are co-repressors that, like MTA subunits of NurD com-
plexes [9], exert their function through association with sequence-specific DNA binding transcrip-
tion factors (TFs). With the hypothesis that such TFs should regulate the same gene networks as
BAHD1, we used the Ingenuity Pathway Analysis Upstream Regulator software to predict TFs
responsible for differential gene expression in BAHD1-deficient or -overexpressing cells. This
analysis identified seven TFs that were consistently found as upstream regulators of a set of BAH-
D1-associated genes in all transcriptome datasets: ESR1, ESR2, EPAS1 (HIF2α), PPARG, FOS,
TP53 and SP1 (S7 Table), the latter being previously reported to associate with BAHD1 [12] and
MIER1 [32]. It is striking that these TFs have relevance both in placental development and regula-
tion of genes involved in lipid/steroid metabolism ([33–36] and other references in S1 Text).
Since ESR1 has been shown to bind MIER1 [37] and to cooperate with SP1 [38], we hypoth-
esized that BAHD1-MIER could act as co-repressors for ESR1-mediated transcriptional regula-
tion. Based on this assumption, BAHD1 should target the ESR1 gene itself, because ESR1
autoregulates its own expression [39]. Accordingly, ESR1 was up-regulated in Bahd1-KO pla-
centas (Fig 3C), as well as in HEK293-FT cells depleted of BAHD1 with siRNA (Fig 6A).
siRNA-mediated knockdown of individual MIER genes did not significantly change expression
of ESR1 in HEK293-FT cells, but combined knockdown of MIER1 and MIER3 (MIER2 was
undetectable) increased ESR1 expression (Fig 6A). We also found that expression of PGR
(encoding the progesterone receptor), which has an ESR1 binding site in its proximal region
[40] significantly increased in BAHD1- and MIER1/3-knockdown cells (Fig 6A), whereas the
androgen receptor transcript (AR) was unaffected. These results indicate that BAHD1 and
MIER1/3 act as repressors for the steroid hormone receptor genes ESR1 and PGR.
BAHD1 knockdown or overexpression induce epigenetic changes at the
ESR1 locus
Human ESR1 forms a large and complex genetic unit that spans approximately 300 kb of chro-
mosome 6 (chr6), of which 140 kb containing 8 protein-coding exons [41]. It is transcribed
from at least seven promoters into multiple transcripts that vary in their 5’-UTRs and whose
expression is tissue-specific. To find out whether the BAHD1-associated complexes targets
ESR1, we analyzed the DNA captured with BAHD1 and its associated partners in the TAP
assays by using real-time PCR with primers targeting the proximal region of ESR1 at, or in the
vicinity of ESR1-binding sites identified by ChIP-seq (Fig 6B, [40], ENCODE ChIP-seq data).
(E2). Eluted fractions were separated by SDS-PAGE and analyzed by Mass Spectrometry. A. Silver staining
of E2.B. Immunoblots of inputs E1 and E2, using antibodies against the specified proteins (for G9a, also see
S4 Fig). C. Schematic representation of MTA1, RERE, MIER1 and BAHD1. ELM2, SANT, BAH domains,
cPRR region and amino-acid numbers are indicated.D. Schematic diagrams of NurD and BAHD1 co-
repressor complexes. Different protein paralogs can be part of distinct complexes. E-F.Nuclear extracts from
HEK293-FT cells expressing BAHD1-V5 or YFPc-BAHD1, YFPc-BAHD1- ΔcPRR, YFPc-BAHD1- ΔBAH
were used in immunoprecipitations (IP) assays with MIER1 or V5 antibodies or IgG control (E) or YFP
antibodies. Vertical lines indicate cropping sites in original blots (see S5 Fig). (F). Eluted fractions were
separated by SDS-PAGE and analyzed by immunoblot with the indicated antibodies (α-). In (F), the MIER1
blot was stripped and reprobed with YFP antibodies (see S5 Fig for a replicate experiment).
doi:10.1371/journal.pgen.1005898.g004
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Fig 5. BAHD1 increases MIER1 nuclear translocation and recruitment to Xi. A. Cytoplasmic, nuclear
soluble or chromatin extracts from HPT-control or HPT-BAHD1 cells induced 30 h with doxycyline were
analyzed by immunoblotting with BAHD1, MIER1, histone H3 or Tubulin-α antibodies. H3 and Tubulin were
used as loading controls.B. Colocalization of Protein-C tagged-BAHD1 and MIER1 on heterochromatic Xi
(pointed with arrows on the merged image) was examined by IF with Protein-C and MIER1 antibodies. Bar,
5 μm. C. Localization of BAHD1 and MIER1 in HPT-BAHD1 cells induced or not for 30 h with doxycycline.
Enrichment on Xi was determined by IF with BAHD1 (top panels) or MIER1 (bottom panels) antibodies
combined with Xist RNA FISH (red). DNA was stained with DAPI (blue in the merged image). Bars: 10 μm.
doi:10.1371/journal.pgen.1005898.g005
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Fig 6. Depletion or overexpression of BAHD1 in HEK293 cells induce epigenetic changes at ESR1. A. BAHD1 and MIER1/3 repress ESR1 and PGR.
HEK293-FT cells were transfected for 72 h with control or BAHD1, MIER1 or MIER3 siRNA. The levels of BAHD1,MIER1,MIER3, ESR1, PGR and AR
transcripts were quantified by RT-qPCR. Data are expressed as mean ± SD (* P<0.05; ** P<0.005). B. Schematic representation of the proximal region of
ESR1 in chr6 of the human genome.C. BAHD1 binds the proximal region of ESR1. Amounts of DNA precipitated with BAHD1-TAP E1 eluates (see Fig 4) or
with control TAP or inputs were quantified using qPCR with the primer sets indicated in B. The amount of DNA purified with BAHD1 was normalized to the
amount precipitated in the control TAP, and to theGAPDH locus. Data are averages ± SD of qPCR triplicates, and representative of 2 independent TAP
experiments. D. BAHD1 depletion alters the patterns of H3K9 acetylation and methylation at the ESR1 locus. HEK293-FT cells were transfected with control
or BAHD1 siRNA and enrichment of H3K9ac, H3K9me2 and H3K9me3 relative to IgG control at ESR1 andGAPDH regions were estimated by ChIP-qPCR in
BAHD1-depleted and control cells. The y-axis shows the relative fold change of ChIP enrichment in cells with BAHD1 siRNA over cells with control siRNA in
Log2 ratios. Data are averages ± SD of two ChIP per antibody and representative of three biological replicates (see S6 Fig). E.Overexpression of BAHD1
induces widespread DNAmethylation at the ESR1 locus. Bisulfite-modified genomic DNA of control HEK-CT cells and isogenic HEK-BAHD1 cells
overexpressing BAHD1 were sequenced and analyzed for their DNAmethylation status, as described in Libertini et al. (2015) [14]. 300bp-regions with
reproducible gain of methylation in HEK-BAHD1 compared to HEK-CT DNA in two BS-seq replicates (i.e hypermethylated BAHD1-DMRs) were binned into
0.5Mb windows highlighting clusters of hyper-DMRs (shown as red bars). Contiguous clusters define BAHD1-associated domains (“Hyper-BADs”, shown as
black boxes). BAHD1-DMRs are represented by black vertical lines in the track “hyper-DMRs”. Three hypermethylated BADs of chr6 are shown on the top,
with the position of ESR1 indicated by an arrow. A 1 Mb region encompassing the Esr1 locus is magnified below, showing the high density of hypermethylated
BAHD1-DMRs on the whole locus. CpG islands are indicated in green. The position of transcripts is shown below.
doi:10.1371/journal.pgen.1005898.g006
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Regions in C6orf211 (Fig 6B) and GAPDH loci were used as controls. Three sites upstream of
ESR1 were identified as BAHD1 binding sites, when compared to input or control cell DNA
(E2, B2, B1; Fig 6C). To determine whether any change in the chromatin structure occur as a
consequence BAHD1 binding at these sites, we tested the effect of BAHD1 depletion on histone
H3 modifications at lysine 9 (H3K9) by using a ChIP-qPCR assay. We observed a reproducible
increase in histone H3K9 acetylation and decrease in H3K9 dimethylation (H3K9me2) and tri-
methylation (H3K9me3) in cells with siRNA−induced knockdown of BAHD1 expression, rela-
tive to cells treated with control siRNA (Fig 6D and S6 Fig). This effect occurred at all sites of
the ESR1 proximal region surveyed by PCR, but not at the GAPDH control site. This result
strongly suggests that a BAHD1-associated complex containing HDACs and KMTs contrib-
utes to the epigenetic silencing of ESR1.
H3K9 methylation is often linked to DNA methylation and several BAHD1-associated part-
ners are known to interact with DNAmethyltransferases [42–45]. To test whether BAHD1
level also affects DNAmethylation patterns at ESR1, we exploited the DNAmethylome data-
sets of HEK-CT and HEK-BAHD1 cells that we recently obtained by whole-genome bisulfite
sequencing (BS-seq) [14]. In this study, we found that BAHD1 overexpression in HEK293 cells
stimulates de novo DNAmethylation in autosomes at ~80,000 regions that become hyper-
methylated when compared to control cells. These “BAHD1-DMRs” group into large (0.3–6.5
Mb) chromosomal domains, termed BAHD1-Associated Domains (BADs, [14]). We observed
that one such BAD was present on chr6 in a large region containing the ESR1 locus (Fig 6E).
The high density of BAHD1-DMRs located at the ESR1 proximal and gene body regions sug-
gests that BAHD1 overexpression stimulates large-scale epigenetic changes. Taken together,
these results provide evidence that BAHD1-associated complexes induce histone and DNA
modifications that shape repressive chromatin structures.
Discussion
Developmental and physiological roles of BAHD1
The functions of BAHD1-mediated chromatin reorganization in developmental and physio-
logical processes were hitherto unknown. Deletion of Bahd1 in mice does not lead to embry-
onic lethality or anatomical malformations in fetuses. However, murine Bahd1-KO placentas
are small and display histomorphological alterations, including reduced surface area of the lab-
yrinthine zone and a thinner junctional zone and decidua. The lack of trophoblast glycogen
cells is particularly striking, suggesting a failure in the differentiation program. The growth
restriction of Bahd1-KO fetuses is likely to be secondary to defective placental nutrient
exchange resulting from these placental abnormalities. In addition, as there is substantial
deregulation of metabolic genes in Bahd1-KOMEFs, the perinatal death of Bahd1-KO pups
likely results from metabolic defects in embryos. The rare mice surviving beyond birth are
males with a lower weight than controls, associated with decreased fat mass and lower levels of
circulating cholesterol, glucose and leptin. In light of our finding that the transcriptional co-
repressor MIER1 is a key partner of BAHD1, it is striking thatMier1 null mice also show
decreased body weight and reduced levels of circulating glucose and cholesterol (data from The
Mouse Phenotyping Consortium and The Wellcome Trust Sanger Institute, references in S1
Text). This phenocopy is a strong argument in favor of BAHD1 and MIER1 cooperating to
control the expression of genes involved in energy metabolism in somatic tissues.
BAHD1 and MIER proteins define a novel chromatin-repressive complex
Separate studies have shown that MIER1 binds to HDAC1/2, G9a and CDYL [27, 28, 46],
while BAHD1 interacts with proteins involved in heterochromatin formation (e.g. HP1,
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MBD1) and its overexpression is sufficient to compact chromatin [12]. We now bring evidence
that BAHD1 and MIER act in partnership within a novel histone deacetylase complex involved
in gene silencing. First, BAHD1 co-purifies with MIER, HDAC1/2, G9a and CDYL in very dif-
ferent cellular models: human HEK293 cells, as shown here, and mouse ES cells [15]. Second,
as in other subunits of HDAC1/2-associated complexes, MTAs of NuRD [8–10, 25](Fig 4D)
and RERE [26–28] (Fig 4C), a BAH domain is present in BAHD1 and HDAC-interacting
ELM2-SANT domains are present in MIER [27, 46]. We found that a truncation of the BAH
domain in BAHD1 abrogates BAHD1 coimmunoprecipitation with MIER1 and HDAC2.
From this, we propose that MTA, RERE and BAHD1-MIER define related macromolecular
complexes of the “NuRD superfamily” and to name “BAHD1 complexes” those containing a
BAHD1 subunit, as BAHD1 has no homolog or isoform. MIER1, MIER2 and MIER3 could be
incorporated into distinct BAHD1 complexes leading to functional redundancy and/or con-
text-dependent functions, as described for MTA1, MTA2 and MTA3. MIER1 is the most abun-
dant partner of BAHD1 in HEK293 cells and its nuclear localization, including at the Xi,
depends on BAHD1 expression levels. This translocation is likely to have functional conse-
quences, as MIER1 nuclear/cytoplasmic distribution varies with cell type and stage of differen-
tiation [47, 48]. Bahd1- andMier1-KO adult mice share common phenotypes but a prenatal
growth restriction is not reported forMier1-KO; hence, the BAHD1-associated regulatory gene
network in embryonic tissues likely involves other partners than MIER1.
Regulation of metabolism gene networks by BAHD1
Genes altered in Bahd1-KO placentas or embryonic fibroblasts are mainly up-regulated com-
pared to wild type controls, consistent with BAHD1 acting as a repressor. The most significant
biological process associated with these genes, and with those repressed in BAHD1-overexpres-
sing human HEK293 cells, is steroid metabolism. This functional convergence is striking and
consistent with the observed hypocholesterolemia and hypolipidaemia in Bahd1-KO mice. We
observed that genes associated with this biological function in Bahd1-KOMEFs and HEK-
BAHD1 cells (e.g. DHCR24,HMGCS1, LDLR, NSDHL, SREBF2, SC4MOL)mostly differ with
those in Bahd1-KO murine placentas (e.g. Apoc3, Atp8b1, Cyp11A1, Insig2, Osbpl5, Pbx1,
VldlR). Thus, like many other chromatin repressors [2], BAHD1 regulates distinct targets in
different tissues and at different developmental stages. However, some of the BAHD1 bona fide
target genes can be common to different biological systems, as exemplified by the steroid hor-
mone receptor gene ESR1. BAHD1 binds the proximal region of human ESR1 and represses
ESR1 both in human cells and murine placentas. In addition, changes in BAHD1 expression
levels in HEK293 cells alter the patterns of H3K9 modifications and DNA methylation at the
ESR1 locus, which is consistent with the interaction of BAHD1 with HDACs, KMTs, HP1 and
MBD1 and the crosstalk between histone and DNAmodifications [49].
It is worth mentioning that MTA1 [50] and SIN3a [39] have also been shown to represses
ESR1 in other cell types, indicating that different HDAC complexes control the epigenetic
silencing of ESR1. Recruitment of BAHD1 at specific sites of the genome might rely on the
combinatorial assembly of BAHD1-MIER subunits with transcription factors. The product of
ESR1 itself (ESR1/ERα) could be one such TF targeted by BAHD1 complexes because ESR1
autoregulates its own expression [39] and MIER1 has been shown to bind ESR1 [37]. In line
with this hypothesis, ESR1 is predicted to control several genes differentially expressed in
BAHD1-KO tissues, such as PGR. In addition, ESR1 cooperates with SP1 [38], a TF known to
bind BAHD1 and MIER1 [12, 32], and which is also predicted to drive BAHD1-associated
transcriptional changes. Our analysis also suggests that BAHD1 could act as a co-repressor
with PPARγ and HIF2α, which like ESR1 are known to play roles in the regulation of energy
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metabolism and placental cell differentiation [33–36]. This raises the plausible hypothesis that
the BAHD1-associated chromatin complex could act as a transcriptional co-repressor in syn-
ergy with different TFs in the context of placental functions and lipid metabolism.
Role of BAHD1 in shaping the placental differentiation program
Placenta morphogenesis depends on the correct balance of cytotrophoblast proliferation and
differentiation, into either syncytiotrophoblast involved in nutrient/gas exchange or invasive
extravillous trophoblast involved in establishment of blood flow to the placenta. It is proposed
that ESR1 controls the proliferation of estrogen-dependent cells, while ESR2 controls their
maturation, hence trophoblast differentiation is associated with the transition from Esr1 to
Esr2 expression [51, 52]. By maintaining unbalanced expression of Esr1 at an inappropriate
time of the gestation, BAHD1 deficiency could disturb trophoblast differentiation. Pgr and
Lepr genes are also deregulated in Bahd1-KO placentas; this should affect progesterone and
leptin signaling, also important in placental development [53, 54]. Therefore, BAHD1 could
play a role in trophoblast differentiation, in particular in the formation of glycogen-producing
cells, by controlling hormone signaling in a timely manner, particularly in the junctional zone,
an important endocrine region. Knockdown of Bahd1 in the mouse placenta results in up-regu-
lation of several other genes that also have relevance to placental development. Among them,
Htra3 and Tfpi2 are two confirmed imprinted genes expressed from the maternally inherited
allele [24]. Maternally expressed genes have been proposed to limit maternal resource provi-
sion; thus up-regulation of such genes is consistent with a placental growth restriction observed
upon BAHD1 deficiency. In fact, HtrA3 and Tfpi2 are highly transcribed in the placenta and
involved in the regulation of endothelial function, trophoblast migration and invasion [55–58].
Further studies will be required to explore whether BAHD1 directly targets these genes and
contributes to their imprinting.
Roles of BAHD1 in diseases
With the importance of the placenta in the feto-maternal exchange processes, as well of steroid
signaling in the body, alterations in the amounts or activity of BAHD1 may lead to various
pathological processes. We previously identified a role for BAHD1 in infection of epithelial
cells with the bacterial pathogen Listeria monocytogenes [11, 31]. The fact that BAHD1 is
involved in placental function now opens the possibility that BAHD1 contributes to the feto-
placental step of listeriosis, as L.monocytogenes has a tropism for the placenta. More generally,
a connection between BAHD1 and placenta-associated pathologies, such as Intrauterine
Growth Restriction and Pre-Eclampsia, should be carefully examined. BAHD1-mediated regu-
lation of ESR1 is also enticing as ESR1 is a key regulator in a variety of biological processes and
ESR1 deregulation has been implicated in several diseases, including breast cancer [59]. A shift
from nuclear to cytoplasmic localization of MIER1 during breast cancer progression has been
observed, suggesting that nuclear MIER1 contributes to the repression of genes involved in
invasive breast carcinoma [37]. Similar to chromatin-repressive complexes Polycomb and
NuRD [9, 60], BAHD1 could be implicated in the regulation of transcriptional events involved
in diverse oncogenic pathways. Of note, insertion events in BAHD1 andMIER1 genes were
identified in a screen for genes that cooperate with oncogenic KRAS (G12D) to accelerate
tumorigenesis and promote progression in a mouse model of pancreatic ductal preneoplasia
[61]. Our data also implicate BAHD1 in mammalian metabolic regulation and several BAHD1
candidate target genes have been associated with metabolic diseases in humans. For instance,
genetic polymorphisms in CRABP2 are associated with changes in plasma cholesterol levels
[62], SNPs in LPL and LASS4 are associated with dyslipidemia [63–65], changes in expression
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levels of HMGCS1, LDLR and SC4MOL correlated with obesity-related type 2 diabetes and car-
diovascular diseases [66]. Together, these results indicate that dysfunction of BAHD1 com-
plexes could promote aberrant epigenetic phenomena at the origin of different disorders.
Detailed understanding of how and where BAHD1 complexes establish repressive chromatin
states could be instrumental for the development of new strategies for selective treatment of
metabolic disorders in the future.
Methods
Ethics statement
Mice were bred and maintained in the animal facilities of the Institut Clinique de la Souris
(ICS, Illkirch, France) under pathogen-free conditions. The ICS facilities are licensed by the
French Ministry of Agriculture (agreement #A67-218-37). All animal procedures were
approved by the local ethical committee CREMEAS (registered under the reference “C2EA–
35”), and were supervised by M.F.C. and O.W. who are qualified in compliance with the Euro-
pean Community guidelines for laboratory animal care and use (2010/63/UE Directive).
Cell lines, plasmids, antibodies, siRNAs and immunostaining
Human cell lines derive from HEK293 cells (ATCC CRL-1573): the HPT-BAHD1 inducible
line and its isogenic HPT-control are described in [11]; the HEK-BAHD1 constitutive line and
its isogenic HEK-CT control are described in [14]; HEK293-FT are from Invitrogen (Thermo-
Fisher Scientific). Plasmid pcV5-BAHD1 (BUG2289), pYFPc (also named pEYFP-Citrine-N1,
BUG2897), pYFPc-BAHD1 (BUG2897) and pYFPc-BAHD1-ΔBAH (BUG2740) are described
in [12]. pYFPc-BAHD1ΔcPRR (BUG2897) is described in [31]. Antibodies were against
BAHD1 (Abcam, 46573), MIER1 (Sigma, HPA019589), HDAC1 (Abcam, ab7028), HDAC2
(Abcam, ab7029), HP1γ (Euromedex, 2MOD-1G6-AS), KAP1 (Abcam, ab10483), G9a (MBL
Cliniscience, D141-3), MBD1 (Abcam, ab3753), tubulin α (Santa Cruz, sc5546), H3K9me2
(Abcam ab1220), H3K9me3 (Abcam ab8898), H3K9ac (Upstate/Millipore 07–352), V5 and
V5-HRP (Invitrogen R960-25, R961-25), GFP (Mouse anti-GFP Sigma/Roche 11814460001
used in IP and Rabbit anti-GFP Santa-Cruz sc-8334, used in WB, which both recognize YFPc)
and control IgG mouse (Santa-Cruz sc-2025) and IgG rabbit (Santa-Cruz sc-2027). Fluorescent
secondary antibodies were from Jackson ImmunoResearch or Molecular Probes, and HRP-
conjugated secondary antibodies were from AbCys or Abcam (IgG Veriblot for IP, ab131368).
siRNAs were purchased from Dharmacon (ThermoFisher Scientific) as follows: on-TARGET-
plus Non-targeting pool (D-001810-10-20), BAHD1 (L-020357-01), MIER1 (M-014201-02),
MIER2 (M-023917-01), MIER3 (M-015618-01). Cells were transfected 72h with siRNA using
Lipofectamine RNAimax (Life Technologies, Grand Island, NY) according to the manufac-
turer's instructions. Immunofluorescence and XIST FISH assays were as described in [12].
Mice breeding and phenotyping
Bahd1+/- mice have been described in [11]. Mice were bred and maintained in the animal facili-
ties of the Institut Clinique de la Souris (ICS, Illkirch, France) under pathogen-free conditions.
Throughout the experiment mice were housed in the same climate-controlled stable with a
12h/12h dark-light cycle and handled identically. For wild type and Bahd1-/- production,
Bahd1+/- mice were mated and the day on which a vaginal plug was found was designated 0.5.
Genotyping protocols are described in [11]. Knockout of Bahd1 expression was verified by RT-
qPCR on placenta, MEF and embryo liver samples. Phenotyping methods of Bahd1 heterozy-
gous and knockout mice and isolation of primary mouse embryonic fibroblasts are described
Biological Functions of BAHD1
PLOSGenetics | DOI:10.1371/journal.pgen.1005898 March 3, 2016 18 / 26
in S1 Text. All the data are expressed as mean ± SE. Statistical analysis were performed using a
one way ANOVA tests followed by a Fischer’s PLSD test with significance set at P<0.05.
 P<0.05,  P<0.01,  P<0.0001.
Microarray processing and analysis
Total RNAs were extracted from Bahd1+/+ and Bahd1-/- placentas at E16.5 (n = 6/genotype) or
E18.5 (n = 3/genotype), as well as from Bahd1+/+ and Bahd1-/- MEFs (n = 3/genotype) and
HEK-CT and HEK-BAHD1 cells (n = 3/cell line) using RNeasy Kit (Qiagen), treated TURBO
DNA-freeTM kit (Ambion). RNA concentration and integrity were tested with RNA quality was
monitored on Agilent RNA Pico LabChips (Agilent Technologies, Palo Alto, CA). 100 ng of
RNA per sample were used as templates for the synthesis of hybridization probes for Affymetrix
GeneChipMicroarrays (Genechip HuGene 1.0 ST for HEK-CT and HEK-BAHD1 cells; Mouse
gene 1.0 for E16.5 placentas; Mouse Exon 1.0 ST for E18.5 placentas and MEFs). Hybridization
was carried out with biological replicates according to the expression analysis technical manual
with wash and stain kit (Affymetrix). Gene-level expression values were derived from the CEL
file probe-level hybridization intensities using the model-based Robust Multichip Average algo-
rithm (RMA) [67]. RMA performs normalization, background correction and data summariza-
tion. An analysis is performed using the LPE test [68] and a p-value threshold of p<0.05 is used
as the criterion for expression. The estimated false discovery rate (FDR) of this analyze was calcu-
lated using the Benjamini Hochberg approach in order to correct for multiple comparisons.
Results were annotated using information provided by Affymetrix. Full data sets were reduced by
discarding genes with “EST” and “unknown” annotation labels. To generate functional clusters
of genes, we used the DAVID program (http://david.abcc.ncifcrf.gov, 2015 version; [20]) for
selected gene sets according to gene ontology (GO) of biological process categories. To search for
transcriptional regulators driving the differential gene expression changes we used the Ingenuity
Pathway Analysis Upstream Regulator software [69]. Datasets have been deposited in Gene
Expression Omnibus (GEO) and are accessible through accession number, as follows: GEO series
GSE51868 (transcriptomes of HEK-CT and HEK-BAHD1); GSE53443 and GSE53442 (tran-
scriptome of Bahd1-WT and Bahd1-KO placentas at E16.5 and at E18.5) and GSE73816 (tran-
scriptome of Bahd1-WT and Bahd1-KOMEFs).
RNA extraction and quantification of transcript levels
Total RNA from HEK293-CT and HEK-BAHD1 cells, HEK293-FT cells treated 72h with siR-
NAs, or from mouse placentas or MEFs was extracted using the RNeasy Kit (Qiagen), from
three to six biological replicates. Genomic DNA was removed by treatment with TURBO
DNA-freeTM kit (Ambion). cDNAs were generated from 1 to 2 μg total RNA using the
RT2-HT first strand kit (Qiagen/SABiosciences). Quantitative Real-Time PCR was performed
on Biorad MyiQ device (Biorad), using SsoFast Evagreen supermix (Biorad), as specified by the
supplier. Each reaction was performed in triplicate. Data were analyzed by the ΔΔCt method.
Target gene expression data were normalized to the relative expression of human GAPDH or
mouse Gapdh (and Hprt, for imprinted genes) and YWHAZ was used as a control gene. Statis-
tical significance of the difference in mean expression of genes was evaluated using the Student
t test; a P value<0.05 was considered significant. Primer sets are provided in S1 Text.
Tandem affinity purification of BAHD1-associated proteins and DNA,
nuclear protein and chromatin immunoprecipitations
The TAP-TAG protocol to purify the partners of His6-Protein-C-tagged BAHD1 in
HPT-BAHD1 cell is described in [11]. Modifications to this protocol, Mass spectrometry
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analysis and precipitation of the associated DNA are detailed in S1 Text. Immunoprecipitation
(IP) of nuclear proteins was performed as described in [70] with the following modifications.
Nuclear soluble and insoluble fractions were sonicated, mixed and incubated overnight at 4°C
with 1–3μg of the indicated antibodies and then with Dynabeads Protein G (#10004D, Novex)
at 4°C during 2h30. IPs were washed 4 times with washing buffer (Tris 20mM pH = 7,65, NaCl
150mM, 0,05% IGEPAL, 2,5% Glycerol, 0,5mM EDTA, 0,6mM DTT). Samples were resus-
pended in 1X Laemmli and boiled at 95°C for 10 min. Proteins were separated on 8–10%
SDS-PAGE gels, transfered to nitrocellulose membrane, probed with primary and secondary
antibodies and detected by chemiluminescence (SuperSignal West Femto Substrate #34094,
ThermoFisher Scientific). Blots were visualized on Films (Amersham) or using a ChemiDoc
MP Imaging system (Bio-Rad). ChIP of modified H3K9 were performed in three independent
biological replicates, using the ChIP-IT Express Enzymatic Kit (Active Motif) according to
manufacturers instructions. Briefly, HEK293-FT cells were grown in T150 flasks for 72h with
either siRNA against BAHD1 or non-targeting control siRNA (up to 70–90% confluency). One
flask was kept for RNA extraction and quantification of BAHD1 knockdown by RT-qPCR.
Cells from other flasks were harvested and cross-linked with a final concentration of 1% form-
aldehyde (Sigma-Aldrich) for 10 minutes. Fixation was stopped with 0.125 M glycine and cells
were washed twice with ice-cold PBS. Collected cells were lysed and nuclei pellet were resus-
pended in shearing cocktail and incubated for digestion for 10 minutes at 37°C. Shearing effi-
ciency was tested by agarose gel electrophoresis and DNA concentration was quantified with a
Nanodrop 2000 (ThermoFisher Scientific) to normalize the quantity of chromatin per ChIP.
For each ChIP, 3 μg of antibody were used. 10 μL of chromatin was kept as input and processed
as ChIP samples. After washing and reverse crosslinking of precipitated samples, DNA was
purified by two extractions with equal volumes of phenol:chloroform:isoamylalcohol (25:24:1,
pH = 8), assisted by phase lock heavy gel tubes (5Prime), followed by ethanol precipitation. Pel-
lets were washed once in 75% ethanol, then resuspended in 50 μL DNAse-free water. H3K9ac,
H3K9me2 and H3K9me3 enrichment levels were measured by qPCR with primers matching
in the ESR1 locus and the non-target control GAPDH region (primer sets are provided in S1
Text). A standard curve was generated using 10%, 1%, 0.1% and 0.01% of input DNA. We first
determined the fold enrichment of the ChIP sample relative to the IgG sample and then the
effect of BAHD1 knockdown on H3K9 modifications was calculated as the ratio of enrichment
in cells treated with BAHD1 siRNA to that in cells treated with control siRNA (presented in
Fig 6 and S6 Fig as a Log2 ratio).
Supporting Information
S1 Text. Additional methods, references, results and discussion.
(PDF)
S1 Fig. Blood chemistry on samples collected from Bahd1-KO and Bahd1-WT mice. A.
Blood sample analysis of 11–20 week-old Bahd1-KO and Bahd1-WT mice fasted for 4 hours
(n = 5/genotype). B. Blood sample analysis of 18 month-old Bahd1-KO and Bahd1-WT mice
fasted for 16 hours (n = 4/genotype). Data are expressed as the mean ± SE ( P<0.05;
 P<0.01).
(TIF)
S2 Fig. Effects of the Bahd1-null mutation in the E16.5 placenta and fetal liver. A.Histolog-
ical analysis and Bahd1+/+ and Bahd1−/− E16.5 placentas with Periodic acid-Shiff (PAS) stain-
ing at two magnifications (10-fold and 16-fold). Clusters of vacuolated glycogen cells are
abundant in WT placentas and severely reduced in Bahd1-KO placentas. Hatched lines
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delineate decidua basalis (Db) and junctional zone (Jz). B.Histological analysis and Bahd1+/+
and Bahd1−/− E16.5 livers with hematoxylin and eosin (HE) staining. Magnification 20-fold.
Squared regions highlight hepatic cells.
(TIF)
S3 Fig. Expression of BAHD1, IGF2 andMIER1 transcripts in response to induction of
BAHD1 in HPT-BAHD1 cells. RT-qPCR quantification of transcript levels in HPT-BAHD1
cells relative to HPT-Control cells, grown 72h with doxycycline (n = 3 for each condition).
Values are normalized by GAPDH. Data are expressed as mean ± SD (ns, non-significant;
 P<0.001).
(TIF)
S4 Fig. Raw images for the western blots used in Fig 4B. Results of the double-affinity purifi-
cation of HPC-tagged BAHD1 were validated by western blot analysis of inputs and eluates from
the 1st and 2nd affinity purifications (E1 and E2) from chromatin extracts of HPT-BAHD1 cells
(“BAHD1”) or HPT-control cells (Control). Membranes were often cut in two pieces to detect
proteins of different molecular weight, enabling to check sample loading with a common anti-
body (α-) (e.g. HDAC1, HDAC2, histones H3 or H4). However, this was not always feasible due
to the similar molecular weight of a number of proteins of interest, resulting in overlapping
hybridization signals in the same region of membranes. We thus had to perform several loadings
of the same samples on distinct gels.A. Raw images of blots detecting HPC-tagged BAHD1 with
Protein C antibodies. H4 was used as a loading control for inputs (same membrane, cut horizon-
tally and probed with H4 antibodies). B. Raw images of blots detecting G9a with G9a antibodies.
In Fig 4B, E1 and E2 lanes were cut to follow the order of samples used when probing with the
other antibodies. FT indicates the column flow through. HDAC2 was used as a loading control
(same membrane, cut horizontally). C. Raw images of blots detecting KAP1 with KAP1 antibod-
ies. HDAC1 was used as a loading control (same membrane, cut horizontally).D. Raw images of
blots detecting MIER1 with MIER1 antibodies. HDAC2 was used as a loading control (same
membrane, cut horizontally). E. Raw images of blots detecting MBD1 with MBD1 antibodies. F.
Raw images of blots for HDAC1 and HDAC2 using HDAC1 and HDAC2 antibodies, respec-
tively. HDAC1 and HDAC2 having the same size, two different blots were performed.G. Raw
images of the blots detecting HP1γ with HP1γ antibodies.
(TIF)
S5 Fig. Co-immunoprecipitation (IP) assays of BAHD1 with several partners. A. Raw
images of western blots used in Fig 4E (top panel) before cropping. IP Ctrl corresponds to the
use of control IgG in IP assays. After IP of BAHD1-V5 (using BAHD1 antibodies) or MIER1
(using MIER1 antibodies), the membrane was first hybridized with V5 antibodies for detection
of BAHD1-V5 (upper panel), then stripped and re-blotted with MIER1 antibodies (lower
panel). The intense bands at the bottom of the lower panel are heavy chains of rabbit IgG used
for the IP, and detected with rabbit secondary antibodies. Note that the BAHD1 antibody is
poorly efficient in immunoprecipitating BAHD1-V5 (top panel, 3rd lane), which can explain
why MIER1 is not detected in the BAHD1 IP (bottom panel, 3rd lane). B. Raw images of west-
ern blots used in Fig 4E (bottom panel) before cropping. After IP of BAHD1-V5 using V5 anti-
bodies, the membranes were probed with V5-HRP (top) or MIER1 (bottom) antibodies. The
background signal, which is visible in the IP control, is due to cross-reactivity with IgG and
protein G affinity matrix used for the IP. C. IPs with IgG Mouse (IP M Ctrl), V5, HP1γ, IgG
Rabbit (IP R Crtl) or HDAC2 antibodies were loaded on a membrane that was cut and probed
with V5-HRP antibodies (top) or HP1γ antibodies. Note that the V5 immunoblot is the same
as in B, before cropping and with a longer exposure time.D. After IP with HDAC2 antibodies,
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the membranes were probed with HDAC2 (top) or MIER1 (bottom) antibodies. On the top,
the IP control and IP HDAC2 samples were diluted 1/100 compared to other IPs, since the sig-
nal of immunoprecipitated HDAC2 is strong and colocalizes near IgG heavy chains. In C and
D, HDAC2 copurifies with low amounts of BAHD1, MIER1 and HP1γ, which might be
explained by the fact that HDAC2 belongs to many distinct macromolecular complexes. E. IP
assays of YFPc-BAHD1 or truncated mutants in HEK293-FT cells. Nuclear extracts from
HEK293-FT cells expressing YFPc-BAHD1, YFPc-BAHD1-ΔcPRR or YFPc-BAHD1-ΔBAH
were used in IP assays with mouse YFP antibodies followed by immunoblotting with rabbit
HDAC2, MIER1 or YFP antibodies or mouse HP1γ antibodies. The last lane shows the
HDAC2 blot stripped and reprobed with YFP antibodies. This experiment is a replicate of Fig
4F, except that in Fig 4F we used IgG Veriblot secondary antibodies to minimize the detection
of light-chains (IgG) of the HP1γ primary antibody.
(TIF)
S6 Fig. BAHD1 depletion alters the patterns of H3K9 acetylation and methylation at the
ESR1 locus.HEK293-FT cells were transfected with control or BAHD1 siRNA in three inde-
pendent biological replicates (A, B, C). We performed one (A, B) or two (C, left and right his-
tograms) ChIP per antibody and respective mouse or rabbit control IgG, for each modified
H3K9. Enrichment of H3K9ac, H3K9me2 and H3K9me3 relative to IgG control at ESR1 and
GAPDH regions were estimated by ChIP-qPCR in BAHD1-depleted and control cells (as in Fig
6). Histograms show the relative fold change of ChIP enrichment in cells with BAHD1 siRNA
over cells with control siRNA in Log2 ratios. Results of replicate 3 (C) are shown in Fig 6D.
(TIF)
S1 Table. BAHD1 is expressed at a low level in different tissues.
(PDF)
S2 Table. Blood chemistry in Bahd1 haplodeficient mice compared to wild type littermates.
(PDF)
S3 Table. Genes differentially expressed in Bahd1-KO compared to Bahd1-WT placentas at
both E16.5 and E18.5 stages.
(PDF)
S4 Table. Biological processes associated with genes deregulated in Bahd1-KO murine pla-
centas, Bahd1-KOMEFs and in human HEK-BAHD1 cells.
(PDF)
S5 Table. Overlap between Bahd1-KOMEFs, Bahd1-KO placentas (E18.5) and human
HEK-BAHD1 cells transcriptome datasets.
(PDF)
S6 Table. Tandem-affinity-purification of BAHD1-associated partners.
(PDF)
S7 Table. Transcription factors predicted to regulate BAHD1-associated genes using the
Ingenuity's Upstream Regulator Analysis.
(PDF)
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